BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
EGFR
,
T cell receptor signaling pathway
,
Pseudomonas infection
,
Kidney
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
slco1b1* 15
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for slco1b1* 15
Explore Curated Studies Results
Literature
Most Relevant Literature
SLCO1B1 *15 allele is associated with methotrexate-induced nausea in pediatric patients with inflamm…
Associations among Plasma Concentrations of Edoxaban and M-4, Prothrombin Time, and the SLCO1B1*15 H…
Effects of the SLCO1B1*15 allele on the pharmacokinetics of pitavastatin.
SLCO1B1 *15 haplotype is associated with rifampin-induced liver injury.
Life-threatening toxicities in a patient with UGT1A1*6/*28 and SLCO1B1*15/*15 genotypes after irinot…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clar…
Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided D…
Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Prava…
Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myoto…
THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ